Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Human CK-MB Polyclonal Antibody

Catalog #:   PHC21102 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P06732 & P12277
Overview

Catalog No.

PHC21102

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human CK-MB.

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Creatine kinase M chain, Creatine phosphokinase M-type, Creatine kinase M-type, CKMM, CKM, CPK-M, M-CK, Creatine phosphokinase B-type, Creatine kinase B-type, CKBB, CPK-B, Brain creatine kinase, Creatine kinase B chain, B-CK, CKB

Concentration

0.65 mg/ml

Purification

Purified by antigen affinity column.

Accession

P06732 & P12277

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CK-MB antibody (PHC21102) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 44 kDa
    Observed MW: 44 kDa
References

Novel Aptamers Targeting Sclerostin Loop3 Improve Skeletal and Muscle Properties Without Adverse Cardiovascular Effects in Orchiectomized Mice., PMID:40464222

Update Breast Cancer 2024 Part 3 - Patients with Advanced Stage Breast Cancer., PMID:40386501

The Hidden Threat in Immunoassays: A Case of Persistent False-Positive CK-MB., PMID:40340875

Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World Study., PMID:40325793

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate., PMID:40121972

Preclinical B cell depletion and safety profile of a brain-shuttled crystallizable fragment-silenced CD20 antibody., PMID:40118783

Myocardial injury and its association with venom-induced coagulopathy following Bothrops atrox snakebite envenomation., PMID:40058470

A capillary-based microfluidic chip prepared via multiple coating and used for a multiplex immunoassay., PMID:39938419

Short-term effects of COVID-19 vaccines on cardiac biomarkers: A comparative study between Pfizer/BioNTech and Sinopharm., PMID:39925818

A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in healthy volunteers., PMID:39923743

Nanoparticle biosensors for cardiovascular disease detection., PMID:39681229

Cardioprotective Efficacy of Quercetin against Cardiotoxicity Induced by Different Diameters of Sphere Gold Nanoparticles (GNPs)., PMID:39660526

Analysis of immunological and biochemical parameters after booster dose vaccination using protein-based and inactivated virus vaccine for safety., PMID:39584086

SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa., PMID:39576151

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma., PMID:39476124

A ring resonators optical sensor for multiple biomarkers detection., PMID:39418982

Time-restricted eating with or without a low-carbohydrate diet improved myocardial status and thyroid function in individuals with metabolic syndrome: secondary analysis of a randomized clinical trial., PMID:39227921

Revealing patient characteristics and treatment outcomes among ultra-long users of biologics for psoriasis., PMID:39140237

Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast Cancer., PMID:38884028

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma., PMID:38828984

Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany., PMID:38755541

ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies., PMID:38701407

Mutation of PTEN: Loss and Likelihood of Being a Non-responder to Trastuzumab in a Sample of Iraqi Her2+ Breast Cancer Patients., PMID:38524002

Sintilimab and Cardiovascular Toxicity-Reply., PMID:38512236

Clinical Effect Analysis of Different Doses of Creatine Phosphate Sodium Combined with Immunoglobulin in the Treatment of Pediatric Viral Myocarditis., PMID:38509207

Rapid diagnosis of acute myocardial infarction through integrated microfluidic chips for detection of characteristic targets., PMID:38453047

Reduced Monocyte and Neutrophil Infiltration and Activation by P-Selectin/CD62P Inhibition Enhances Thrombus Resolution in Mice., PMID:38385292

The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials., PMID:38292716

Interferon-regulatory factor-1 boosts bevacizumab cardiotoxicity by the vascular endothelial growth factor A/14-3-3γ axis., PMID:38234115

A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2., PMID:38140172

Hyperoside Protects Trastuzumab-Induced Cardiotoxicity via Activating the PI3K/Akt Signaling Pathway., PMID:37943365

Antitumor activities against breast cancers by an afucosylated anti-HER2 monoclonal antibody H2 Mab-77-mG2a -f., PMID:37942574

Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast Cancer., PMID:37916184

The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production., PMID:37888620

Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial., PMID:37824808

One-Stop Plasmonic Nanocube-Excited SERS Immunoassay Platform of Multiple Cardiac Biomarkers for Rapid Screening and Progressive Tracing of Acute Myocardial Infarction., PMID:37821412

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity., PMID:37794185

HMGB1-RAGE axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte autophagy and apoptosis in diabetic mice., PMID:37768929

Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy., PMID:37754285

A capillary-based microfluidic chip with the merits of low cost and easy fabrication for the rapid detection of acute myocardial infarction., PMID:37437393

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants., PMID:37433788

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma., PMID:37219943

CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia., PMID:37205201

Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity., PMID:36968065

Update Breast Cancer 2022 Part 6 - Advanced-Stage Breast Cancer., PMID:36908287

Cardiac Effects of Micrurus corallinus and Micrurus dumerilii carinicauda (Elapidae) Venoms and Neutralization by Brazilian Coralsnake Antivenom and Varespladib., PMID:36813862

Clinical Efficacy of Early Administration of Human Immunoglobulin on Children with Severe Hand-foot-mouth Disease., PMID:36797638

Infliximab substantially re-silenced Wnt/β-catenin signaling and ameliorated doxorubicin-induced cardiomyopathy in rats., PMID:36636964

Exploring the potential molecular mechanism of trastuzumab-induced cardiotoxicity based on RNA sequencing and bioinformatics analysis., PMID:36563885

Protective effect of adenosine triphosphate and benidipine separately or together against cardiotoxicity caused by bevacizumab., PMID:36484126

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CK-MB Polyclonal Antibody [PHC21102]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only